Info Session

A summary of the grants are below for your convenience:

These grants provide up to $50,000 to advance early-stage technologies in the validation or proof-of-concept phase. The award is intended to add value to the technology and increase the probability of licensing.

  • Prototype development
  • Biological target validation and screening
  • Animal model development
  • Other advanced pre-commercial research

These grants provide up to $150,000 to advance later-stage technologies whose concept has been proven. Like the pilot grant, this award is intended to add value to the technology and increase the probability of licensing to an established company or startup. Development grants can be used for:

  • Prototype development
  • Human clinical studies
  • Pre-clinical data packaging
  • Drug delivery development
  • Large animal studies
  • Other advanced pre-commercial research.


*Note: Awarded projects must be completed within 12-18 months from the initial payment. A minimum of 70 percent of the project must be performed by a contract research organization (CRO).

2021 Schedule and Deadlines

Item Date
Letter of Intent (LOI) May 17 by EOD (5pm EDT)
Feedback July
Full Proposal & Final Presentation Slides August
Advisory Board Presentation September
Award Announcement November/December

Eligibility criteria

  1. The application must be based on intellectual property (IP) developed at Boston Children’s Hospital with the rights assigned to the hospital. The principal investigator must be a Boston Children’s employee.
  2. A complete invention disclosure must be on file with the Technology and Innovation Development Office (TIDO).
  3. For TDGs, at least one patent application for the technology should be filed with the U.S. Patent and Trademark Office prior to submission of the Letter of Intent. The patent strategy and commercialization path for the technology must be well defined.

Applying for Grants

  1. File an invention disclosure with your TIDO Licensing Manager, if you have not already done so.
  2. Review the evaluation criteria below as well as the TDF Guidelines and Policies.
  3. Click below to download the Letter of Intent.
  4. Fill out the form and submit by May 17, 2021.

Successful applications are invited to submit a Full Proposal and make a brief presentation to an external advisory board.

Evaluation criteria

The TDF’s reviewers, both internal and external, look at the following:

  • Medical need or research significance
  • Path to market
  • Alignment with hospital’s mission
  • The potential impact of the grant
  • Technical feasibility
  • Freedom to operate
  • Stage of development

Selected applicants will be invited to submit the full proposal.

  1. Prepare a brief 15-minute presentation for the external advisory board. It is recommended that applicants follow the presentation guidelines provided.
  2. Attend the day-long External Advisory Board Presentation.


Following the Advisory Board Presentation, TDF will release award announcements. Awardees who have been selected to receive funding will prepare and submit a project plan.

Because the evaluation and selection process will place a strong emphasis on the project’s commercial potential, applicants are encouraged to contact TDF to discuss the full proposal as well as the format and content of the presentation.

For additional information, please contact us at technology.development@childrens.harvard.edu.